Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
doi: 10.1126/science.aan3706 182 MikEVidaAKovcsTUjlakiGTrencsnyiGMrtonJet al
the modified-release formulation may be better tolerated
Tirzepatide produced 20.2% average weight loss at 72 weeks
US$ 26.75
US$ 22.35
US$ 24.86
US$ 22.04
US$ 20.40
US$ 25.43
US$ 28.54
US$ 21.86
US$ 26.52
US$ 25.81
US$ 28.41
US$ 26.12
US$ 27.08
US$ 21.56
US$ 27.92
